Articles by Roger Dabbah - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Roger Dabbah

A Quality-Control Guide Fails to Train the Trainer

A book about developing quality-control training manuals provides a wealth of information and a dearth of practical help.
Aug 2, 2011

A book about developing quality-control training manuals provides a wealth of information and a dearth of practical help.

An Unfocused Handbook on Environmental Monitoring

An expert-panel-written book has surprising shortcomings.
Oct 20, 2010

An expert-panel-written book has surprising shortcomings.

An Unfocused Handbook on Environmental Monitoring

An expert-panel-written book has surprising shortcomings.
Oct 2, 2010

An expert-panel-written book has surprising shortcomings.

More Than You Need to Know about Manufacturing Pharmaceutical Proteins

The author of a book about biopharmaceutical production includes irrelevant information.
Aug 2, 2009

The author of a book about biopharmaceutical production includes irrelevant information.

No Excuse for Nonconformance

An updated book provides essential information for scientists who monitor microbial quality.
Mar 2, 2009

An updated book provides essential information for scientists who monitor microbial quality.

A Guide That Perplexes

Despite its flaws, a recent release fills a need for books about pharmaceutical project management.
Aug 2, 2008

Despite its flaws, a recent release fills a need for books about pharmaceutical project management.

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

Jul 1, 2001

USP ensures the microbiological quality of products by way of the development, proposal, and acceptance of general information chapters.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here